Thrive Health Solutions
Thrive Health Solutions is a 503A compounding pharmacy based in Englewood, CO. A government record names semaglutide and tirzepatide at Thrive Health Solutions; the newest is an FDA warning letter dated February 9, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from Thrive Health Solutions without a prescription from a licensed clinician.
How to get a GLP‑1 filled by Thrive Health SolutionsChecked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.
Thrive Health Solutions at a glance
How to get a GLP‑1 filled by Thrive Health Solutions
To get a GLP‑1 from Thrive Health Solutions, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.
These are the three programs ranked highest on our score. Check that a program ships to your state before you sign up.
- 1Health questionnaire, online
- 2A licensed clinician decides
- 3The pharmacy ships to you
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Prefer your own clinician? You’re free to: ask them to send your prescription to Thrive Health Solutions or another licensed pharmacy.
See every program we rankWhat ties Thrive Health Solutions to GLP‑1s
- FDA warning letterFebruary 9, 2026 · tirzepatideFDA warning letter WL # 714891 to Thrive Health and Wellness, LLC1
“MEGALean (Tirzepatide/Cyanocobalamin) Injections 10mg/20mg/mL”
- FDA recallMay 21, 2025 · semaglutideClass II recall D-0480-2025: Lack of Assurance of Sterility2
“Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · semaglutideClass II recall D-0479-2025: Lack of Assurance of Sterility3
“Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · semaglutideClass II recall D-0481-2025: Lack of Assurance of Sterility4
“Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · tirzepatideClass II recall D-0484-2025: Lack of Assurance of Sterility5
“Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · tirzepatideClass II recall D-0485-2025: Lack of Assurance of Sterility6
“Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · tirzepatideClass II recall D-0482-2025: Lack of Assurance of Sterility7
“Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · tirzepatideClass II recall D-0486-2025: Lack of Assurance of Sterility8
“Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA recallMay 21, 2025 · tirzepatideClass II recall D-0483-2025: Lack of Assurance of Sterility9
“Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- FDA inspection report (Form 483)April 3, 2025 · semaglutide and tirzepatideFDA Form 483 inspectional observations, Thrive Health and Wellness, LLC, issued 2025-04-0310
“Two lots of syringes containing Tirzepatide injection produced on 3/24/2025”
Thrive Health Solutions’s FDA record
| Date | What the FDA did |
|---|---|
| February 9, 2026 | Warning Letter (02/09/2026)1 |
| April 3, 2025 | 483 issued 04/03/202511 |
What a compounded GLP‑1 is, and what it isn’t
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.1415 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.1312
Thrive Health Solutions: questions
- 1.FDA warning letter WL # 714891 to Thrive Health and Wellness, LLCFDAretrieved 2026-02-09↩“MEGALean (Tirzepatide/Cyanocobalamin) Injections 10mg/20mg/mL”
- 2.Class II recall D-0480-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 3.Class II recall D-0479-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 4.Class II recall D-0481-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 5.Class II recall D-0484-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 6.Class II recall D-0485-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 7.Class II recall D-0482-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 8.Class II recall D-0486-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 9.Class II recall D-0483-2025: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2025-05-21↩“Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112”
- 10.FDA Form 483 inspectional observations, Thrive Health and Wellness, LLC, issued 2025-04-03FDAretrieved 2025-04-03↩“Two lots of syringes containing Tirzepatide injection produced on 3/24/2025”
- 11.FDA: 483 issued 04/03/2025 (PDF - 1.34MB)U.S. Food and Drug Administration↩
- 12.Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 13.Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
- 14.
- 15.
A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.